Photonics News and Research

RSS

Growth of OMI equipment sales to reach $400M in 2014

In vivo optical molecular imaging (OMI) is poised to move into clinical use as one of the key tools in personalized medicine, complementing more established imaging tools such as CT and MRI. Growth of equipment sales is on track to reach $400 million in 2014 and nearly $1 billion by the end of the decade.

21 Jan 2010

Zecotek Photonics' Real-Time 3D2D Display System exhibited in Zurich

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that its Real-Time 3D2D Display System is exhibited in Zurich, Switzerland to a select number of European display manufacturers.

20 Jan 2010

Vytran's precision optical fiber processing equipment to be demonstrated

Vytran, an innovative supplier of fiber fusion splicing, assembly and fiber-based glass processing solutions, will demonstrate its precision optical fiber processing equipment at the Photonics West 2010 exhibition from January 26-28 in San Francisco, California.

18 Jan 2010

Zecotek Photonics clarifies news release on TGFL provided to the National Institute of Health

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced an update and clarification to the news release of December 15, 2009 titled "National Cancer Institute Selects Zecotek's Tunable Green Fiber Laser for Applications in Flow Cytometry."

23 Dec 2009

Zecotek Photonics' proprietary TGFL selected for research in flow cytometry

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the National Cancer Institute, a division of the U.S. National Institutes of Health (NIH), has selected its proprietary Tunable Green Fiber Laser (TGFL) for research in flow cytometry.

16 Dec 2009

CONNECT announces the winners of MIP Awards

CONNECT, one of the nation's most successful regional economic development programs for high technology and life science innovators, today announced the winners of the 22nd Annual Most Innovative New Product (MIP) Awards.

11 Dec 2009

Optics Balzers expands its market presence in Europe

Additional important milestones have been reached on the road to success, and the pace continues to be fast. By setting up a sales branch office in France, Optics Balzers as a provider of innovative optical thin-film components and assemblies continues to forge ahead with expanding its presence in Europe.

11 Dec 2009

Axsun Technologies reports successful testing of novel OCT imaging integrated light source architecture

Axsun Technologies, Inc., a wholly-owned subsidiary of Volcano Corporation, today announced the initial development and successful testing of a novel integrated light source architecture for OCT imaging. Axsun believes this proprietary optical engine design raises the bar on imaging speed and overcomes fundamental limitations of laser-based designs for swept source OCT light sources.

4 Dec 2009

Andor Technology reports 2009 preliminary results

ANDOR TECHNOLOGY PLC ("Andor") Preliminary Results for the year ended 30 September 2009 24 November 2009 Andor Technology plc (AND.L), the leading developer and manufacturer of high performance digital cameras and solutions for academic, industrial and government applications globally, today announces preliminary results for the year ended 30 September 2009.

24 Nov 2009

Case Western Reserve images heart tissue through Avo produced OCT catheters

Nearly 4 million people nationwide suffer from cardiac arrhythmias each year, according to the 2006 U.S. Cardiac Rhythm Management Market report by Frost and Sullivan. About 2.5 million of these cases cannot be treated or controlled through medication alone. Since pharmacological therapies have limited effectiveness, radiofrequency (RF) catheter ablation has emerged as the prominent approach for treating a broad range of arrhythmias.

5 Nov 2009

CWRU grants licensing agreement to Bioptigen for FDOCT technology

Case Western Reserve University and University Hospitals Case Medical Center have granted to Bioptigen, of Research Triangle Park, N.C ., an exclusive intellectual property licensing agreement for Fourier domain optical coherence tomography (FDOCT), an imaging technology developed from research at the university's Department of Biomedical Engineering.

27 Oct 2009

Zecotek Photonics increases and closes non-brokered private placement; sells units at $0.63 rate

Zecotek Photonics Inc. (TSX VENTURE:ZMS)(FRANKFURT:W1I), a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that it has increased and subsequently closed the non-brokered private placement previously announced on August 19, 2009.

24 Oct 2009

Light can be manipulated for creative and lucrative ends

The speed of light, 300 million metres per second, was long thought an immutable constant and has defined our understanding of matter and energy but recent research in the area of optics and photonics is proving that we can manipulate light to some ingenious and hugely lucrative ends.

9 Sep 2009

Living cells controlled with light; potential for stem cell research

University of Central Florida researchers have shown for the first time that light energy can gently guide and change the orientation of living cells within lab cultures. That ability to optically steer cells could be a major step in harnessing the healing power of stem cells and guiding them to areas of the body that need help.

12 Aug 2009

"Drops" of gold that burn tumors

At a technical breakfast, Romain Quidant presented his research into the detection and treatment of cancer using gold nanoparticles illuminated with laser light. Quidant, who was recently awarded the Fresnel Prize 2009 that recognizes the highest level of excellence amongst emerging researchers in the field of photonics, is an ICREA researcher at the UPC's Institute of Photonic Sciences (ICFO) and a fellow of the Cellex Foundation Barcelona.

16 Jul 2009

Novel method stimulates growth of new neurons in adult brain

University at Buffalo researchers have identified a new mechanism that plays a central role in adult brain stem cell development and prompts brain stem cells to differentiate into neurons.

21 May 2009

Nanoparticles used to stimulate growth of new neurons in adult brain

University at Buffalo researchers have identified a new mechanism that plays a central role in adult brain stem cell development and prompts brain stem cells to differentiate into neurons.

20 May 2009

New generation of nanotools for ultra-sensitive measurements at the atomic level

As researchers push towards detection of single molecules, single electron spins and the smallest amounts of mass and movement, Yale researchers have demonstrated silicon-based nanocantilevers, smaller than the wavelength of light, that operate on photonic principles eliminating the need for electric transducers and expensive laser setups.

26 Apr 2009

Nanobiotix reports 'proof of concept' for use of nanoparticles in treating glioblastoma multiforme

Nanobiotix has announced that an independent preclinical study has validated the applicability of using its nanoparticles-nanoPDT-to treat glioblastoma multiforme, one of the most prevalent brain tumors. Nanobiotix expects to attract corporate partners for the development of nanoPDT as the Company focuses development efforts on its nanoXray technology.

6 Apr 2009